Lupin in talks with Sanofi arm Zentiva to purchase inhaler brand
Monday, March 6, 2017, 6:08 PM
Indian drug maker Lupin is holding discussions with French pharmaceutical giant Sanofi’s generic arm Zentiva to acquire Pulmojet, its dry powder inhalation brand. The two companies have been negotiating a deal for the last few months and a final transaction will help Lupin sharpen its global inhalation therapy business. The contours of the deal or the valuation could not be immediately known.